Recent findings suggest, however, otherwise and point to a severely altered GABAergic signaling in AD, with possible modulation of tau hyperphosphorylation (Lanctot et al., 2004; Limon et al., 2012; Nykanen et al., 2012). Here, MAPT is linked to Alzheimer disease.